Pharmaceutical company in
Bubendorf

Bachem AG

Since 2003 · 500+ empl.·4.5(4)

Bachem AG develops and manufactures peptides and oligonucleotides as active pharmaceutical ingredients for pharmaceutical and biotechnology companies. Its activities span research synthesis, clinical development, GMP manufacturing and commercial supply, alongside catalog products and analytical, regulatory and project-management services.

BACHEM HOLDING AG

Since 1971 · 11–20 empl.·4.5(4)

BACHEM HOLDING AG develops and manufactures peptides and oligonucleotides as active pharmaceutical ingredients for pharmaceutical and biotechnology companies. Its services span early clinical development through commercial GMP manufacturing, as well as custom synthesis and catalog products.

CARBOGEN AMCIS AG

Since 1982 · 101–500 empl.

CARBOGEN AMCIS AG is a contract development and manufacturing organisation serving the pharmaceutical and biopharmaceutical industries. It develops and manufactures active pharmaceutical ingredients and drug products, supporting projects from early development through commercial supply, and also produces cholesterol and vitamin D derivatives.

CARBOGEN AMCIS INNOVATIONS AG

Since 2019 · 11–20 empl.

CARBOGEN AMCIS INNOVATIONS AG provides development and manufacturing services for pharmaceutical ingredients and drug products. Its activities include process development, analytical services and production from clinical stages through commercial supply, as well as specialty products such as cholesterol and vitamin D derivatives.

CIS Biopharma AG

Since 2023 · 11–20 empl.

CIS Biopharma AG is a biotechnology company developing targeted cancer therapies. Its work includes antibody-drug conjugates, nanobody-drug conjugates and radioligand therapies, with a focus on cancers such as small cell lung cancer, brain metastases and glioblastoma.